Pfizer to launch Lyrica for neurotic pain and seizure therapy.

Pfizer Korea launched Lyrica (pregabalin) for the treatment of neurotic pain and epileptic disease.

Lyrica (pregabalin) capsules is FDA-approved to treat painful diabetic peripheral neuropathy and postherpetic neuralgia by selectively binding with alfa 2 delta protein, a nerve impulse transmittal regulator between brain and spinal cord, to reduce over exciting nerve activities involved in se...